LMAT: LeMaitre Corp Projected Price to Earnings

Brandmark of LeMaitre Vascular, Inc. (LMAT)

Due to product uniqueness and surgeon loyalty, LeMaitre Vascular (LMAT) possesses significant pricing power within its niche. Conservative family management ensures margin transparency and effective patent protection. Revenues are based on the supply of vascular grafts and instruments to major clinics. The company's expected P/E trend reflects the business valuation dynamics, with the metric reaching the level of 24.90.

LMAT - LeMaitre Vascular Market Cap to Projected Earnings over the range 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company LeMaitre Vascular (LMAT)

- stock value and consensus price forecast:
Summary company analysis:LMAT LeMaitre
Signature product of lemaitre.com

For the specialized vascular implant manufacturer LeMaitre Vascular, Inc. (LMAT), this indicator compares market value with expected earnings, revealing the business's ability to generate cash to service its obligations. An analysis of the company's valuation via the forward P/E allows for a distinction between fundamental undervaluation and default risks, confirming the resilience of evolutionary innovations in medical design through the lens of actual cash flow.

Direct competitors

Future Price to Earnings Intuitive Surgical Inc (ISRG)|DHR (Danaher Corp) - Future Price to Earnings Multiple|Forward P/E Multiple BDX (bd.com)|Market Cap to Projected Earnings steris.com (STE)|WST - Future Price to Earnings|BAX (Baxter International Inc.) - Price to Future Earnings Ratio|Masimo Corporation (MASI) - Future Price to Earnings|Price to Future Earnings Ratio STVN|Projected Price to Earnings TFX|Merit Medical (MMSI) - Market Cap to Projected Earnings|Projected Price to Earnings NVST (Envista Holdings)|Market Cap to Future Earnings Ratio ICUI|Future Price to Earnings Dentsply XRAY|Future Price to Earnings Multiple ATRC|STAA: Projected Price to Earnings|NAGE - Forward P/E Multiple|ZimVie Inc (ZIMV) - Future Price to Earnings|Projected Price to Earnings AngioDynamics|CERS (cerus.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Teknova Inc TKNO|Future Price to Earnings Monogram Orthopedics (MGRM)|Sharps Tech - Price to Future Earnings Ratio|InfuSystem Holdings, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio UTMD (Utah Medical Products Inc.)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah S.A NYXH|microbotmedical.com (MBOT) - Future Price to Earnings|Price to Expected Earnings Ratio PDEX (pro-dex.com)|ZTEK (Zentek Corp) - Forward P/E Multiple|Future Price to Earnings ELUT|Future Price to Earnings Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Future Earnings Ratio|Forward P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Future Price to Earnings|FEMY - Future Price to Earnings|MHUA - Forward P/E Multiple|POAI: Forward P/E Multiple|Price to Future Earnings Ratio CJMB|Projected Price to Earnings ATRI|Projected Price to Earnings Ratio NeuroMetrix NURO